Antivirals are medications that help your body fight off certain viruses that can cause disease. Antiviral drugs are also preventive.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Antivirals industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Generic
Branded
Market Segment by Product Application
Application I
HIV
Hepatitis
HSV
Influenza
Finally, the report provides detailed profile and data information analysis of leading company.
Merck
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma
Cipla
Dr Reddy's
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Antivirals consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Antivirals market by identifying its various subsegments.
3.Focuses on the key global Antivirals manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Antivirals with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Antivirals submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Antivirals Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Antivirals Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Antivirals Segment by Type
2.1.1 Generic
2.1.2 Branded
2.2 Market Analysis by Application
2.2.1 Application I
2.2.2 HIV
2.2.3 Hepatitis
2.2.4 HSV
2.2.5 Influenza
2.3 Global Antivirals Market Comparison by Regions (2017-2027)
2.3.1 Global Antivirals Market Size (2017-2027)
2.3.2 North America Antivirals Status and Prospect (2017-2027)
2.3.3 Europe Antivirals Status and Prospect (2017-2027)
2.3.4 China Antivirals Status and Prospect (2017-2027)
2.3.5 Japan Antivirals Status and Prospect (2017-2027)
2.3.6 Southeast Asia Antivirals Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Antivirals Industry Impact
2.5.1 Antivirals Business Impact Assessment - Covid-19
2.5.2 Market Trends and Antivirals Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Antivirals Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Antivirals Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Antivirals Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Antivirals Manufacturer Market Share
3.5 Top 10 Antivirals Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Antivirals Market
3.7 Key Manufacturers Antivirals Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Antivirals Industry Key Manufacturers
4.1 Merck
4.1.1 Compan Detail
4.1.2 Merck Antivirals Product Introduction, Application and Specification
4.1.3 Merck 164 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Merck News
4.2 Johnson & Johnson
4.2.1 Compan Detail
4.2.2 Johnson & Johnson Antivirals Product Introduction, Application and Specification
4.2.3 Johnson & Johnson Antivirals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Merck News
4.3 Teva Pharmaceutical Industries
4.3.1 Compan Detail
4.3.2 Teva Pharmaceutical Industries Antivirals Product Introduction, Application and Specification
4.3.3 Teva Pharmaceutical Industries Antivirals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Teva Pharmaceutical Industries News
4.4 GSK
4.4.1 Compan Detail
4.4.2 GSK Antivirals Product Introduction, Application and Specification
4.4.3 GSK Antivirals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 GSK News
4.5 Mylan
4.5.1 Compan Detail
4.5.2 GSK Antivirals Product Introduction, Application and Specification
4.5.3 Mylan Antivirals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Mylan News
4.6 Gilead Sciences
4.6.1 Compan Detail
4.6.2 Gilead Sciences Antivirals Product Introduction, Application and Specification
4.6.3 Gilead Sciences Antivirals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Gilead Sciences News
4.7 F. Hoffmann-La Roche
4.7.1 Compan Detail
4.7.2 F. Hoffmann-La Roche Antivirals Product Introduction, Application and Specification
4.7.3 F. Hoffmann-La Roche Antivirals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Bristol-Myers-Squibb
4.8.1 Compan Detail
4.8.2 Bristol-Myers-Squibb Antivirals Product Introduction, Application and Specification
4.8.3 Bristol-Myers-Squibb Antivirals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Bristol-Myers-Squibb News
4.9 AbbVie
4.9.1 Compan Detail
4.9.2 AbbVie Antivirals Product Introduction, Application and Specification
4.9.3 AbbVie Antivirals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 AbbVie News
4.10 Aurobindo Pharma
4.10.1 Compan Detail
4.10.2 Aurobindo Pharma Antivirals Product Introduction, Application and Specification
4.10.3 Aurobindo Pharma Antivirals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Aurobindo Pharma News
4.11 Cipla
4.11.1 Compan Detail
4.11.2 Cipla Antivirals Product Introduction, Application and Specification
4.11.3 Cipla Antivirals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Cipla News
4.12 Dr Reddy's
4.12.1 Compan Detail
4.12.2 Dr Reddy's Antivirals Product Introduction, Application and Specification
4.12.3 Dr Reddy's Antivirals Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Dr Reddy's News
5 Global Antivirals Market Segment by Big Type
5.1 Global Antivirals Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Antivirals Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Antivirals Revenue and Market Share by Big Type (2017-2022)
5.2 Generic Sales Growth Rate and Price
5.2.1 Global Generic Sales Growth Rate (2017-2022)
5.2.2 Global Generic Price (2017-2022)
5.3 Branded Sales Growth Rate and Price
5.3.1 Global Branded Sales Growth Rate (2017-2022)
5.3.2 Global Branded Price (2017-2022)
6 Global Antivirals Market Segment by Big Application
6.1 Global Antivirals Sales Market Share by Big Application (2017-2022)
6.2 Application I Sales Growth Rate (2017-2022)
6.3 HIV Sales Growth Rate (2017-2022)
6.4 Hepatitis Sales Growth Rate (2017-2022)
6.5 HSV Sales Growth Rate (2017-2022)
6.6 Influenza Sales Growth Rate (2017-2022)
7 Global Antivirals Forecast
7.1 Global Antivirals Revenue, Sales and Growth Rate (2022-2027)
7.2 Antivirals Market Forecast by Regions (2022-2027)
7.2.1 North America Antivirals Market Forecast (2022-2027)
7.2.2 Europe Antivirals Market Forecast (2022-2027)
7.2.3 China Antivirals Market Forecast (2022-2027)
7.2.4 Japan Antivirals Market Forecast (2022-2027)
7.2.5 Southeast Asia Antivirals Market Forecast (2022-2027)
7.2.6 Other Regions Antivirals Market Forecast (2022-2027)
7.3 Antivirals Market Forecast by Type (2022-2027)
7.3.1 Global Antivirals Sales Forecast by Type (2022-2027)
7.3.2 Global Antivirals Market Share Forecast by Type (2022-2027)
7.4 Antivirals Market Forecast by Application (2022-2027)
7.4.1 Global Antivirals Sales Forecast by Application (2022-2027)
7.4.2 Global Antivirals Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Antivirals Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Antivirals Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Antivirals
Figure Market Concentration Ratio and Market Maturity Analysis of Antivirals
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Antivirals Market Size by Big Type
Figure Global Market Share of Antivirals by Big Type in 2021
Figure Generic Picture (2017-2022)
Global Antivirals Market Size by Big Application
Table Global Antivirals Market Size by Application
Figure Global Antivirals Market Share by Big Application in 2021
Figure Application I Picture
Figure HIV Picture
Figure Hepatitis Picture
Figure HSV Picture
Figure Influenza Picture
Table Global Antivirals Comparison by Regions (M USD) ?2017-2027?
Figure Global Antivirals Market Size (Million US$) (2017-2027)
Figure North America Antivirals Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Antivirals Revenue (Million US$) Growth Rate (2017-2027)
Figure China Antivirals Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Antivirals Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Antivirals Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Antivirals Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Antivirals Sales by Manufacturer (2017-2022)
Figure Global Antivirals Sales Market Share by Manufacturer in 2021
Table Global Antivirals Revenue by Manufacturer (2017-2022)
Figure Global Antivirals Revenue Market Share by Manufacturer in 2021
Table Global Antivirals Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Antivirals Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Antivirals Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Antivirals Market
Table Key Manufacturers Antivirals Product Type
Table Mergers & Acquisitions Planning
Table Merck Company Profile
Table Antivirals Product Introduction, Application and Specification of Merck
Table Antivirals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Johnson & Johnson Company Profile
Table Antivirals Product Introduction, Application and Specification of Johnson & Johnson
Table Antivirals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson Recent Development
Table Teva Pharmaceutical Industries Company Profile
Table Antivirals Product Introduction, Application and Specification of Teva Pharmaceutical Industries
Table Antivirals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva Pharmaceutical Industries Main Business
Table Teva Pharmaceutical Industries Recent Development
Table GSK Company Profile
Table Antivirals Product Introduction, Application and Specification of GSK
Table Antivirals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GSK Main Business
Table GSK Recent Development
Table GSK Main Business
Table GSK Recent Development
Table Mylan Company Profile
Table Antivirals Product Introduction, Application and Specification of Mylan
Table Antivirals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Mylan Main Business
Table Mylan Recent Development
Table Gilead Sciences Company Profile
Table Antivirals Product Introduction, Application and Specification of Gilead Sciences
Table Antivirals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Gilead Sciences Main Business
Table Gilead Sciences Recent Development
Table F. Hoffmann-La Roche Company Profile
Table Antivirals Product Introduction, Application and Specification of F. Hoffmann-La Roche
Table Antivirals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table F. Hoffmann-La Roche Main Business
Table F. Hoffmann-La Roche Recent Development
Table Bristol-Myers-Squibb Company Profile
Table Antivirals Product Introduction, Application and Specification of Bristol-Myers-Squibb
Table Antivirals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bristol-Myers-Squibb Main Business
Table Bristol-Myers-Squibb Recent Development
Table AbbVie Company Profile
Table Antivirals Product Introduction, Application and Specification of AbbVie
Table Antivirals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AbbVie Main Business
Table AbbVie Recent Development
Table Aurobindo Pharma Company Profile
Table Antivirals Product Introduction, Application and Specification of Aurobindo Pharma
Table Antivirals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Aurobindo Pharma Main Business
Table Aurobindo Pharma Recent Development
Table Cipla Company Profile
Table Antivirals Product Introduction, Application and Specification of Cipla
Table Antivirals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cipla Main Business
Table Cipla Recent Development
Table Dr Reddy's Company Profile
Table Antivirals Product Introduction, Application and Specification of Dr Reddy's
Table Antivirals Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Dr Reddy's Main Business
Table Dr Reddy's Recent Development
Figure Global Antivirals Sales and Growth Rate (2017-2022)
Figure Global Antivirals Revenue and Growth Rate (2017-2022)
Table Global Antivirals Sales by Regions (2017-2022)
Figure Global Antivirals Sales Market Share by Regions in 2021
Table Global Antivirals Revenue by Regions (2017-2022)
Figure Global Antivirals Revenue Market Share by Regions in 2021
Figure North America Antivirals Sales and Growth Rate (2017-2022)
Figure Europe Antivirals Sales and Growth Rate (2017-2022)
Figure China Antivirals Sales and Growth Rate (2017-2022)
Figure Japan Antivirals Sales and Growth Rate (2017-2022)
Figure Southeast Asia Antivirals Sales and Growth Rate (2017-2022)
Figure Other Regions Antivirals Sales and Growth Rate (2017-2022)
Table Global Antivirals Sales by Big Type (2017-2022)
Table Global Antivirals Sales Market Share by Big Type (2017-2022)
Figure Global Antivirals Sales Market Share by Big Type in 2019
Table Global Antivirals Revenue by Big Type (2017-2022)
Table Global Antivirals Revenue Market Share by Big Type (2017-2022)
Table Global Antivirals Revenue Market Share by Big Type in 2019
Figure Global Generic Sales Growth Rate (2017-2022)
Figure Global Generic Price (2017-2022)
Figure Global Branded Sales Growth Rate (2017-2022)
Table Global Antivirals Sales by Big Application (2017-2022)
Table Global Antivirals Sales Market Share by Big Application (2017-2022)
Figure Global Antivirals Sales Market Share by Big Application in 2019
Figure Global Application I Sales Growth Rate (2017-2022)
Figure Global HIV Sales Growth Rate (2017-2022)
Figure Global Hepatitis Sales Growth Rate (2017-2022)
Figure Global HSV Sales Growth Rate (2017-2022)
Figure Global Influenza Sales Growth Rate (2017-2022)
Figure Global Antivirals Sales and Growth Rate (2022-2027)
Figure Global Antivirals Revenue and Growth Rate (2022-2027)
Table Global Antivirals Sales Forecast by Regions (2022-2027)
Table Global Antivirals Market Share Forecast by Regions (2022-2027)
Figure North America Sales Antivirals Market Forecast (2022-2027)
Figure Europe Sales Antivirals Market Forecast (2022-2027)
Figure China Sales Antivirals Market Forecast (2022-2027)
Figure Japan Sales Antivirals Market Forecast (2022-2027)
Figure Southeast Asia Sales Antivirals Market Forecast (2022-2027)
Figure Other Regions Sales Antivirals Market Forecast (2022-2027)
Table Global Antivirals Sales Forecast by Type (2022-2027)
Table Global Antivirals Market Share Forecast by Type (2022-2027)
Table Global Antivirals Sales Forecast by Application (2022-2027)
Table Global Antivirals Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antivirals
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Antivirals Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Antivirals Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Antivirals Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Antivirals Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Antivirals Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Antivirals Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Antivirals Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Antivirals Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Merck
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma